Rectal dose constraints for intensity modulated radiation therapy of the prostate

American Journal of Clinical Oncology
Gregory P Swanson, Sotirios Stathakis

Abstract

Prostate dose escalation appears to have resulted in increased cancer control. Such escalation has been made possible by the ability to deliver more conformal treatment that spares normal tissue from the higher radiation doses. The supposition is that this has enabled higher doses, but without an increase in toxicity. The most disabling toxicity in prostate cancer radiotherapy is rectal. We evaluated the current status of conformal radiation and late rectal toxicity with the goal of determining whether reasonable rectal dose and volume constraints can be determined. Although the literature is inexact, we believe that some generalized constraints can be recommended and show that those recommendations are consistent with what is being used at experienced centers.

References

Jan 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W G SmitB H van der Werf-Messing
Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·G E HanksJ J Diamond
Mar 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S A LeibelS Kramer
Dec 1, 1995·International Journal of Radiation Oncology, Biology, Physics·Y LuG T Chen
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A C HartfordW U Shipley
Jan 1, 1997·International Journal of Radiation Oncology, Biology, Physics·T E SchultheissG E Hanks
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·E DaleS D Fosså
Mar 17, 1999·International Journal of Radiation Oncology, Biology, Physics·D M HeroldG E Hanks
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·J M MichalskiJ D Cox
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·M W SkwarchukC C Ling
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·E E YeohW Sun
Oct 6, 2000·International Journal of Radiation Oncology, Biology, Physics·M R StoreyI Rosen
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·A JacksonC C Ling
Apr 11, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S WachterR Pötter
Jul 16, 2002·Seminars in Radiation Oncology·Michael J ZelefskySteven A Leibel
Aug 15, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dirk VordermarkOliver Kölbl
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Janice K RyuJames D Cox
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Eugene H HuangDeborah A Kuban
Sep 10, 2003·World Journal of Urology·Alan PollackRobert A Price
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Claudio FiorinoRiccardo Valdagni
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerald E HanksUNKNOWN Radiation Therapy Oncology Group
Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Carlo GrecoRoberto Orecchia
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Peter C M KoperPeter Levendag
Mar 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Rex CheungDeborah Kuban
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Susan L TuckerRadhe Mohan
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Almudena ZapateroArmando Pérez-Torrubia
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Massoud al-AbanyGunnar Steineck
Jul 19, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luc J BosEugène M F Damen
Jul 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Carlos VargasJohn W Wong
Jan 18, 2006·International Journal of Radiation Oncology, Biology, Physics·Stephanie T H PeetersPeter C M Koper
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie T H PeetersJoos V Lebesque
May 5, 2006·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dirk BoehmerVolker Budach
Sep 4, 2007·International Journal of Radiation Oncology, Biology, Physics·Deborah A KubanAlan Pollack

❮ Previous
Next ❯

Citations

Dec 10, 2020·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Franco CampostriniManuel Zorzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
L VieillevigneF Julia
Chinese Journal of Cancer
Hui Liu, Joe Y Chang
Journal of Surgical Oncology
N Y Lee, S A Terezakis
© 2021 Meta ULC. All rights reserved